ArticleBone reports2022

Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist.

Masatomo Ogata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.